These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 30918432)

  • 41. Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
    Wu PS; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC
    PLoS One; 2021; 16(10):e0258589. PubMed ID: 34648567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.
    Tseng TC; Peng CY; Hsu YC; Su TH; Wang CC; Liu CJ; Yang HC; Yang WT; Lin CH; Yu ML; Lai HC; Tanaka Y; Nguyen MH; Liu CH; Chen PJ; Chen DS; Kao JH
    Liver Cancer; 2020 Apr; 9(2):207-220. PubMed ID: 32399434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.
    Chen YC; Chu CM; Liaw YF
    Hepatology; 2010 Feb; 51(2):435-44. PubMed ID: 19918971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
    Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.
    Jun T; Hsu YC; Ogawa S; Huang YT; Yeh ML; Tseng CH; Huang CF; Tai CM; Dai CY; Huang JF; Chuang WL; Yu ML; Tanaka Y; Nguyen MH
    Hepatol Commun; 2019 Apr; 3(4):493-503. PubMed ID: 30976740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.
    Takemura K; Takizawa E; Tamori A; Nakamae M; Kubota H; Uchida-Kobayashi S; Enomoto M; Kawada N; Hino M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
    Nah EH; Cho S; Kim S; Kim HS; Cho HI
    J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Kim GA; Han S; Choi GH; Choi J; Lim YS
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
    Kim SU; Heo JY; Kim BK; Park JY; Kim DY; Han KH; Ahn SH; Kim HS
    Liver Int; 2017 Jun; 37(6):879-887. PubMed ID: 27973711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.
    Jun CH; Hong HJ; Chung MW; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    World J Gastroenterol; 2013 Oct; 19(40):6834-41. PubMed ID: 24187458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
    Sasaki R; Yamasaki K; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Bekki S; Kugiyama Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Ichikawa T; Nakao K; Yatsuhashi H
    PLoS One; 2015; 10(6):e0129053. PubMed ID: 26070204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
    Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
    Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
    Kim HS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Park YN; Han DH; Kim KS; Choi JS; Choi GH; Kim HS
    Clin Mol Hepatol; 2020 Jan; 26(1):33-44. PubMed ID: 31243939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response.
    Harimoto N; Itoh S; Yamanaka T; Hagiwara K; Ishii N; Tsukagoshi M; Watanabe A; Araki K; Yoshizumi T; Shirabe K
    Anticancer Res; 2022 Jan; 42(1):245-251. PubMed ID: 34969731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
    Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.